News

Medical Device Network7h
Geneticure’s test obtains US patent to predict renal denervation response
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
Medical Device Network11h
FDA approves Dymicron’s study of cervical artificial disc
The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
Medical Device Network12h
Aqtual secures $31m to commercialise rheumatoid arthritis test
Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.